Search - tctmd.com

Displaying 281 - 300 of 301

Sort: Relevancy | Date

News Daily News

FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin

Michael O'Riordan

June 30, 2016

News Conference News EAS 2016

Preservation of LDL Cholesterol Targets for Lipid Lowering in New European Guidance Gets Blessing of Prevention Experts

Yael L. Maxwell

June 06, 2016

News Daily News

Majority of FDA Advisors Give Green Light to Amplatzer PFO Closure Device for Stroke

Shelley Wood

May 25, 2016

News Conference News ACC 2016

Involving Low-Risk Patients in Chest Pain Test Decisions Eases Fears, Saves Money

Caitlin E. Cox

April 04, 2016

News Daily News

Good Guys, Bad Guys, or Just Big Money? The Push to Link Patient-Claims Data to Device Outcomes

Shelley Wood

March 17, 2016

News Daily News

Unreliable Narrators: Patients Both Over- and Underreport Hospitalizations After Acute MI

Yael L. Maxwell

January 28, 2016

News Daily News

Califf’s Road to FDA Gets Rockier as Senators Place Holds on Process

Shelley Wood

January 26, 2016

News Conference News TCT 2015

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

October 13, 2015

News Conference News TCT 2015

Trial Results Often Struggle to Keep Pace With Evolving Technology

Nicole Lou

October 13, 2015

News Industry News

Thoratec trial pits HeartMate PHP against Abiomed’s Impella

September 04, 2015

News Industry News

Hemostemix Enrolls 20th Participant and Treats 15th in International Clinical Trial for Critical Limb Ischemia

July 27, 2015

News Daily News

MVARC Document Offers Template for Mitral Valve Therapeutics Research

Todd Neale

July 16, 2015

News Industry News

Biotronik launches CRT in women study

July 08, 2015

News Daily News

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

Yael L. Maxwell

June 26, 2015

News Industry News

World's Smallest Pacemaker, Medtronic Micra TPS, Wins Top European Innovation Award for 2015

June 24, 2015

News Industry News

CVRx® Barostim Therapy® for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference

May 26, 2015

News Daily News

ASCERT Cost Analysis: CABG More Expensive Than PCI but Offers Better Outcomes

L.A. McKeown

January 12, 2015

News Daily News

Hybrid Revascularization Still Not Widely Available in US Hospitals Even With Proven Efficacy, Safety

L.A. McKeown

August 07, 2014

News Daily News

Shift in CMS Policy Shines Spotlight on PCI Readmissions

Yael L. Maxwell

July 10, 2012

News Conference News

PRISM Individualized Informed Consent Improves PCI Choice, Experience

November 14, 2011

Advertisement

FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin

Preservation of LDL Cholesterol Targets for Lipid Lowering in New European Guidance Gets Blessing of Prevention Experts

Majority of FDA Advisors Give Green Light to Amplatzer PFO Closure Device for Stroke

Involving Low-Risk Patients in Chest Pain Test Decisions Eases Fears, Saves Money

Good Guys, Bad Guys, or Just Big Money? The Push to Link Patient-Claims Data to Device Outcomes

Unreliable Narrators: Patients Both Over- and Underreport Hospitalizations After Acute MI

Califf’s Road to FDA Gets Rockier as Senators Place Holds on Process

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

Trial Results Often Struggle to Keep Pace With Evolving Technology

Thoratec trial pits HeartMate PHP against Abiomed’s Impella

Hemostemix Enrolls 20th Participant and Treats 15th in International Clinical Trial for Critical Limb Ischemia

MVARC Document Offers Template for Mitral Valve Therapeutics Research

Biotronik launches CRT in women study

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

World's Smallest Pacemaker, Medtronic Micra TPS, Wins Top European Innovation Award for 2015

CVRx® Barostim Therapy® for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference

ASCERT Cost Analysis: CABG More Expensive Than PCI but Offers Better Outcomes

Hybrid Revascularization Still Not Widely Available in US Hospitals Even With Proven Efficacy, Safety

Shift in CMS Policy Shines Spotlight on PCI Readmissions

PRISM Individualized Informed Consent Improves PCI Choice, Experience

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content